FIELD: medicine.
SUBSTANCE: there is offered application of L-tryptophan and L-tryptophan peripheral decomposition inhibitor (preferentially, carbidopa or Benserazide) for making a medicinal agent for prevention or treatment of pain, depression, somnipathy and other serotonin-dependent diseases of central nervous system (CNS) with L-tryptophan being presented by a slow-release drug, and L-tryptophan peripheral decomposition inhibitor - by a fast-release drug.
EFFECT: there is assured constant high concentration of tryptophan in the patient's blood plasma with the real absence of by-effects following administration of the declared combination.
5 cl, 2 dwg, 2 ex
